Compare Enveric Biosciences Inc (ENVB) vs Vanguard International High Dividend Yield ETF (VYMI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Enveric Biosciences Inc vs Vanguard International High Dividend Yield ETF — how do they compare? Enveric Biosciences Inc trades at $1.38 (market cap $5.32M), while Vanguard International High Dividend Yield ETF trades at $101.04. The key difference: Vanguard International High Dividend Yield ETF is trading nearer its 52-week high, Enveric Biosciences Inc nearer its low. Which is the better fit depends on your goals.
| ENVB | VYMI | |
|---|---|---|
Market Cap | $5.32M | — |
Sector | Health | Broad Market / Factor |
52-Week High | $17.40 | $101.60 |
52-Week Low | $1.28 | $79.95 |
Enterprise Value | $408.82K | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ENVB trades at $1.38, up 4.55% today, with a bearish technical signal from moving averages but neutral oscillators. The company reported a net loss of $8.77M for 2025, though it beat EPS estimates in all four quarters. Recent news highlights participation in investor conferences and progress with its neuroplastogen candidate EB-003, including IND-enabling studies and positive preclinical results.
Outlook hinges on clinical progress, with 75% analyst buy ratings supporting potential upside, but high financial losses and negative ROE/ROA pose significant risks. Investors face volatility from regulatory developments and funding needs, making it speculative despite positive sentiment from recent operational updates.
VYMI trades at $101.07, up 0.28% with a bullish technical outlook supported by strong moving average signals and a 44.04 ADX indicating strong trend momentum. The ETF focuses on international high-dividend stocks with a 0.07% expense ratio and has attracted over $2 billion in inflows in 2026 according to recent reports. Recent dividend payments and positive media coverage highlight its income-generating potential.
The outlook remains positive given international diversification benefits and strong dividend growth potential. Key risks include currency fluctuations and global economic volatility. Analysts favor VYMI for its low-cost structure and exposure to undervalued international markets compared to US counterparts.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Enveric Biosciences Inc
Enveric Biosciences is a biotechnology company focused on developing next-generation psychedelic-inspired therapies for mental health and neuropsychiatric disorders.
Read more on ENVB →About Vanguard International High Dividend Yield ETF
VYMI is an index-based ETF that provides exposure to non-U.S. companies across developed and emerging markets that are characterized by high dividend yields. It tracks the FTSE All-World ex US High Dividend Yield Index, offering a diversified, low-cost way to capture international income while serving as a tactical hedge against U.S. market concentration.
Read more on VYMI →
